More PRNewswire
View Older Stories View Newer Stories-
Marengo Presents Initial Phase 2 Results Demonstrating Broad Single-Agent Activity of Invikafusp Alfa Across Multiple PD-1-Refractory or -Resistant Solid Tumors as a Late-Breaking Oral Presentation at
-
Apnimed To Present Additional Phase 3 Data for AD109, an Investigational Oral Pill for Obstructive Sleep Apnea, at CHEST 2025 Annual Meeting
-
Terex Announces Third Quarter 2025 Financial Results Conference Call
-
Delivering on Voters' Priority for Higher Education and Training Could Add $20 Billion to Arizona's Economy
-
Dogness Reports Financial Results for Fiscal Year Ended June 30, 2025
-
Streamline QuickBooks Workflow Instantly with ezCheckPrinting Virtual Printer Combo
-
ATLASSIAN WILLIAMS RACING CHOSEN BY NMC² AS OFFICIAL LAUNCH PARTNER
-
OpenInfra Summit Europe Kicks Off in Paris: OpenInfra is the Resilience Playbook for AI, Sovereignty and VMware Migrations
-
Autoliv: Financial Report July - September 2025
-
Aker Carbon Capture ASA (under liquidation): Minutes from Extraordinary General Meeting
-
Truekind® to Launch TrueCool Wireless Menopause Bra and TrueCool Mid-Waist Menopause Brief
-
NeuralTrust spots first signs of "self-fixing" AI in the wild
-
ZENITH BANK PLC WINS BIG AT GLOBAL BRANDS AWARDS 2025
-
Ally Financial reports third quarter 2025 financial results
-
Natural Grocers® Invites Customers to a "Spooktacular" Family-Friendly Halloween Event, Oct. 25, 2025
-
Manar Abu Dhabi Reveals Artist Line-Up for Second Edition
-
Gibson Garage Miami - The Ultimate Guitar Experience - To Open in Miami, Spring 2026
-
Harts Plumbers, Electricians & HVAC Technicians share tips for choosing a home service provider
-
New Book Blends Baseball with Themes of Family, Faith, and Life's Miracles
-
Huntington Bancshares Incorporated Reports 2025 Third-Quarter Earnings
-
Bank of America Announces Redemption of €1,750,000,000 1.949% Fixed/Floating Rate Senior Notes, due October 27, 2026
-
Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.
-
Resilience Expands Coverage for Technology Errors & Omissions Insurance for Clients Above $25M In Annual Revenue
-
CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
-
WESTERN MIDSTREAM ANNOUNCES THIRD-QUARTER 2025 DISTRIBUTION AND EARNINGS CONFERENCE CALL
-
Nick Cohen, Doral Renewables' CEO, Honored by Goldman Sachs as one of the Most Exceptional Entrepreneurs at the 2025 Builders and Innovators Summit
-
Comerica Reports Third Quarter 2025 Earnings Results
-
A Journey to Elegant Life -- LEPAS Global Journey of Elegant Driving (China Stop) Concludes Successfully
-
Colossal's Toddler of the Year Campaign Raises $12.7 Million to Support Toys for Tots
-
Weekly Recap: 11 Finance Press Releases You Need to See
-
One Heung Kong Leads the Way! New Global Benchmark for Healthy Living Announced
-
Weekly Recap: 11 Tech Press Releases You Need to See
-
Omio's annual NowNext '25 report reveals a new era of intentional travel
-
BingX Achieves ISO 27001 Certification, Setting the Standard for Web3 Information Security
-
RhythmX AI Collaborates with Microsoft to Deliver Hyper-Personalized Care Through Dragon Copilot
-
Truist reports third quarter 2025 results
-
Weekly Recap: 14 Health Press Releases You Need to See
-
Erayak Power Solution Group Inc. Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy
-
Weekly Recap: 13 Consumer Press Releases You Need to See
-
Yiren Digital Strategically Expands into Blockchain Finance and Partners with ChainUp for Platform Development
-
Minesto part of Swedish high-level delegation to South Korea
-
B2PRIME Accelerates Institutional Expansion with Strategic Hires from iSAM Securities
-
13 Press Releases You Need to See This Week
-
AEON Expands to Georgia with Local QR-Based Crypto Payments
-
GRAINGER ANNOUNCES AGREEMENT TO DIVEST CROMWELL
-
Hyperscale Data Declares Monthly Cash Dividend of $0.2708333 per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock
-
XAG Receives FAO Global Excellence in Sustainable Plant Production and Protection
-
Kelun-Biotech's Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC
-
SEMIFIVE Submits Securities Registration for KOSDAQ Listing
-
Bybit to List ZEROBASE (ZBT) on Spot
